Epilepsy Today first reported on the responsive neurostimulator (RNS) back in 2006, when nobody knew if it could be effective for treating epilepsy. After several years of trials and its recent FDA approval, the first epilepsy patient has had the implant procedure. The operation took place at the Keck School of Medicine at the University of Southern California, US.
The RNS is an implant that learns the ‘signature’ of a person’s seizures. When it senses that signature, it sends an electronic charge, stopping the seizure before it starts.